Bioprocess Analyzers Market Report 2026

The bioprocess analyzers market size has grown rapidly in recent years. It will grow from $2.18 billion in 2025 to $2.4 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to growing biopharmaceutical production, rising adoption of automation in labs, increasing demand for biologics, regulatory compliance requirements, advancement in sensor technologies.

The bioprocess analyzers market size is expected to see strong growth in the next few years. It will grow to $3.35 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to expansion of personalized medicine, integration of ai in bioprocessing, demand for continuous manufacturing, growth of contract manufacturing organizations (cmos), development of miniaturized analytical systems. Major trends in the forecast period include real-time bioprocess monitoring, process analytical technology (pat) integration, high-throughput screening & automation, advanced sensor development, quality-by-design (qbd) implementation.

The rise in demand for biopharmaceuticals is expected to drive the growth of the bioprocess analyzer market going forward. Biopharmaceuticals are drugs derived from biological sources, including living organisms or their components. The biopharmaceutical industry is expanding due to innovative research and development efforts that result in new biologics and biosimilars. Bioprocess analyzers are employed to monitor key parameters during biopharmaceutical production, such as cell growth, protein expression, and product purity. For instance, in January 2024, according to IQVIA, a US-based provider of biopharmaceutical development services, global spending on biotech is projected to surpass $892 billion by 2028. Therefore, the rise in demand for biopharmaceuticals is driving the growth of the bioprocess analyzer market.

Major companies in the bioprocess analyzer market are focusing on developing advanced solutions, such as optical in-line analyzers, to strengthen their competitive position. Optical in-line analyzers are instruments that use optical technology to provide real-time monitoring and analysis of critical parameters in bioprocessing applications. For instance, in September 2023, 908 Devices Inc., a US-based chemical and biochemical analysis company, launched MAVERICK, an advanced optical in-line analyzer that offers real-time monitoring and control of essential factors, including glucose, lactate, and total biomass in mammalian cell cultures. Biopharmaceutical professionals can use the device’s comprehensive process fingerprint data to optimize large-scale bioprocesses. Its user-friendly design streamlines tasks for scientists and engineers, accelerating the development of cell culture media and the creation of effective feeding and control strategies. Using Raman spectroscopy, MAVERICK measures critical process parameters such as glucose, lactate, and biomass in bioreactors in real time. It is designed to enhance process understanding, optimize performance, and ensure batch-to-batch consistency in cell culture automation for biologic production with CHO (Chinese hamster ovary) or HEK293 (human embryonic kidney 293) cell lines and multiple media types.

In June 2023, Waters Corporation, a US-based analytical technologies company, expanded its collaboration with Sartorius to deliver integrated bioanalytics solutions for downstream biomanufacturing. The partnership seeks to improve process efficiency, ensure product quality, and accelerate biologics development by combining advanced analytical platforms with streamlined workflow solutions, supporting innovation and growth in biopharmaceutical manufacturing. Sartorius is a Germany-based life sciences company specializing in bioprocessing and laboratory technologies.

Major companies operating in the bioprocess analyzers market are Danaher Corporation, Merck KGaA, Thermo Fisher Scientific, MilliporeSigma, Sartorius AG, Beckman Coulter Inc., Waters Corporation, Bio-Rad Laboratories, Bruker Corporation, Agilent Technologies, GE Healthcare, Pall Corporation, HORIBA Ltd., Nova Biomedical, Hamilton Company, BioTek Instruments, PerkinElmer Inc, Analytik Jena AG, Eppendorf AG, Metrohm AG, Zymo Research Corporation, Macherey-Nagel GmbH & Co. KG.

North America was the largest region in the bioprocess analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioprocess analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have introduced challenges for the bioprocess analyzers market by increasing costs of imported analytical instruments, sensors, and consumables. The impact is particularly felt in high-end instruments and advanced sensor segments, affecting North America and Europe due to reliance on Asian manufacturing hubs. While tariffs may slow adoption due to higher prices, they have also encouraged local manufacturing and innovation, creating opportunities for regional suppliers to expand their market presence.

The bioprocess analyzers market research report is one of a series of new reports that provides bioprocess analyzers market statistics, including bioprocess analyzers industry global market size, regional shares, competitors with a bioprocess analyzers market share, detailed bioprocess analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the bioprocess analyzers industry. This bioprocess analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Bioprocess analyzers are analytical devices or systems designed to monitor, evaluate, and control various factors and processes involved in the production of biopharmaceuticals, bioprocessing, and biotechnology. They are used across multiple sectors to ensure the efficiency and quality of bioprocessing operations and provide real-time monitoring and management of critical parameters.

The main types of bioprocess analyzer products include instruments and consumables. Instruments are essential tools in bioprocessing, allowing for precise measurement, analysis, control, and optimization of processes to achieve desired outcomes in product yield, quality, and efficiency. They are applied in areas such as antibiotics, recombinant proteins, biosimilars, and other applications, and are utilized by end users including biopharmaceutical companies, contract manufacturing organizations, contract research organizations, and others.

The bioprocess analyzers market consists of sales of biosensors, spectroscopic sensors, spectrophotometers, and biochemical analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.